News

BMA explains why it gave up GP primary care monopoly

25-Jul-08

Hamish Meldrum
Allowing alternative providers into general practice was inevitable, BMA Council chairman Dr Hamish Meldrum has said.

Speaking to the BMA’s GPs-to-be conference yesterday, Dr Meldrum explained his decision to give up the GP monopoly on primary care when negotiating the new contract.

Diversity of providers was ‘something that was happening anyway’, he said.

He added that it was necessary if GPs were to have greater control of their workload. ‘If we’re able to say no, then somebody else has got to be able to say yes,’ he said.

Dr Meldrum also criticised the ‘knee-jerk negativity’ with which GPs often greet government policy.

‘Don't be put off by older, disillusioned GPs,’ he told the younger doctors.

jonn.elledge@haymarket.com

Comment below and tell us what you think

Comments

JOHN PIKE

25/07/2008

Is it any wonder that the older GPs feel disillusioned after 3 zero percent pay awards, annual unilateral changes by HMG to a contract which they agreed to in good faith, the endless bureaucracy and the daily criticism of them by HMG and the media?

Maybe younger GPs shouldn't be put off by all this; after all, British General Practice is still the envy of the world, but it would be as well if younger GPs were fully aware of how serious the situation is at present.

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more